SCFAs, serving as an energy source for colonic epithelial cells, could influence the expression of tight junction proteins, enhance intestinal barrier function, activate the AMPK/mTOR pathway, and modulate the immune system, thereby alleviating inflammation state and improving metabolic disorders in diabetic mice. Here, PRKAA1 is linked to Other metabolic disease.